Lytix Biopharma signs licensing agreement
Our member Lytix Biopharma has entered into a milestone agreement
Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.
She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.
Our member Lytix Biopharma has entered into a milestone agreement
Molecular diagnostics, clinical studies and exercise plans for cancer patients were three key topics raised in last week’s event.
Eivind changed his mind last minute to study medtech for cancer patients
A power centre for innovation takes shape in Oslo …
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.